Completed
Pharmacokinetic, Safety, and Tolerability Study of Risperidone ISM® at Different Dose Strengths
NCT01788774
- Conditions
- Mental Disorders, Psychotic Disorders, Schizoaffective Disorder, +2 more
- Locations
-
- Zagreb, Croatia
- Moscow, Russia
- Saint Petersburg, Russia
- Cape Town, South Africa